David Johnson
Director/Board Member at CARIBOU BIOSCIENCES, INC.
Net worth: - $ as of 2024-04-29
David Johnson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 2022-05-10 | - |
| Independent Dir/Board Member | 2022-05-10 | - |
Career history of David Johnson
Former positions of David Johnson
| Companies | Position | Start | End |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-03-11 | 2022-11-30 |
| GILEAD SCIENCES, INC. | Sales & Marketing | 2002-12-31 | 2017-12-31 |
Training of David Johnson
| University of Puget Sound | Undergraduate Degree |
| Kenan-Flagler Business School | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- David Johnson
- Experience
